CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 9,902 shares at $25.18 ($249,302)
- 4 Open-market sale 10% owner sold 183,326 shares at an average $25.56 ($4,685,659)
- 4 Open-market sale 10% owner sold 164,102 shares at an average $26.75 ($4,389,798)
- 4 Planned sale Chief Medical Officer sold 5,000 shares at $25.95 ($129,727)
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 39,562 shares at an average $27.32 ($1,080,730)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Administrative Officer sold 2,500 shares at $25.67 ($64,175)
- 4 Planned sale Director sold 3,500 shares at $25.67 ($89,845)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 274,451 shares at an average $26.46 ($7,262,829)
- 4 Grant or award Director acquired 6,027 shares (grant or award)
- 4 Grant or award Director acquired 6,027 shares (grant or award)
- 4 Grant or award Director acquired 6,027 shares (grant or award)
- 4 Grant or award Director acquired 6,027 shares (grant or award)
- 4 Grant or award Director acquired 6,027 shares (grant or award)
- 4 Grant or award Director acquired 6,027 shares (grant or award)
Page 15 of 41 · 806 filings